Status:
COMPLETED
Music Therapy and Hematopoietic Stem Cell Transplant
Lead Sponsor:
Case Comprehensive Cancer Center
Conditions:
Hematopoietic Stem Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this randomized, controlled study is to determine the effects of pre-transplant music therapy on mood, distress, and physical functioning variables in patients undergoing Hematopoietic ...
Detailed Description
Primary Endpoint: Compare the difference in distress via Distress Thermometer for patients who receive music therapy and those who do not. Secondary Endpoints: Compare the difference in patient per...
Eligibility Criteria
Inclusion
- Patients undergoing inpatient allogeneic stem cell transplant
- Must be fluent in English
- Must be able to communicate verbally and have no significant hearing impairment
- Have capacity to provide consent
- All diagnosis, graft source, donor sources will be included.
Exclusion
- Patients not meeting the above inclusion criteria
Key Trial Info
Start Date :
February 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03378089
Start Date
February 26 2018
End Date
June 21 2019
Last Update
August 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic, Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44195